Tyler DS - Search Results

1

Genomic and molecular profiling predicts response to temozolomide in melanoma.

Augustine CK, Yoo JS, Potti A, Yoshimoto Y, Zipfel PA, Friedman HS, Nevins JR, Ali-Osman F, Tyler DS. Augustine CK, et al. Among authors: tyler ds. Clin Cancer Res. 2009 Jan 15;15(2):502-10. doi: 10.1158/1078-0432.CCR-08-1916. Clin Cancer Res. 2009. PMID: 19147755

2

Positron emission tomography scanning in malignant melanoma.

Tyler DS, Onaitis M, Kherani A, Hata A, Nicholson E, Keogan M, Fisher S, Coleman E, Seigler HF. Tyler DS, et al. Cancer. 2000 Sep 1;89(5):1019-25. Cancer. 2000. PMID: 10964332

3

Marked variability of melphalan plasma drug levels during regional hyperthermic isolated limb perfusion.

Cheng TY, Grubbs E, Abdul-Wahab O, Leu SY, Hung CF, Petros W, Aloia T, Fedrau R, Pruitt S, Colvin M, Friedman H, Tyler D. Cheng TY, et al. Am J Surg. 2003 Nov;186(5):460-7. doi: 10.1016/j.amjsurg.2003.07.019. Am J Surg. 2003. PMID: 14599607

4

Modulation of resistance to regional chemotherapy in the extremity melanoma model.

Grubbs EG, Ueno T, Abdel-Wahab O, Cheng TY, Pruitt SK, Michael Colvin O, Friedman HS, Tyler DS. Grubbs EG, et al. Among authors: tyler ds. Surgery. 2004 Aug;136(2):210-8. doi: 10.1016/j.surg.2004.04.021. Surgery. 2004. PMID: 15300182

5

In-transit melanoma: the role of alkylating-agent resistance in regional therapy.

Grubbs EG, Abdel-Wahab O, Cheng TY, Abdel-Wahab Z, Peterson B, Pruitt SK, Colvin OM, Friedman HS, Tyler DS. Grubbs EG, et al. Among authors: tyler ds. J Am Coll Surg. 2004 Sep;199(3):419-27. doi: 10.1016/j.jamcollsurg.2004.05.271. J Am Coll Surg. 2004. PMID: 15325612

6

Temozolomide is a novel regional infusion agent for the treatment of advanced extremity melanoma.

Ueno T, Ko SH, Grubbs E, Pruitt SK, Friedman HS, Tyler DS. Ueno T, et al. Among authors: tyler ds. Am J Surg. 2004 Nov;188(5):532-7. doi: 10.1016/j.amjsurg.2004.07.014. Am J Surg. 2004. PMID: 15546565

7

Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicity.

Ko SH, Ueno T, Yoshimoto Y, Yoo JS, Abdel-Wahab OI, Abdel-Wahab Z, Chu E, Pruitt SK, Friedman HS, Dewhirst MW, Tyler DS. Ko SH, et al. Among authors: tyler ds. Clin Cancer Res. 2006 Jan 1;12(1):289-97. doi: 10.1158/1078-0432.CCR-05-0210. Clin Cancer Res. 2006. PMID: 16397054

8

Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine.

Ueno T, Ko SH, Grubbs E, Yoshimoto Y, Augustine C, Abdel-Wahab Z, Cheng TY, Abdel-Wahab OI, Pruitt SK, Friedman HS, Tyler DS. Ueno T, et al. Among authors: tyler ds. Mol Cancer Ther. 2006 Mar;5(3):732-8. doi: 10.1158/1535-7163.MCT-05-0098. Mol Cancer Ther. 2006. PMID: 16546988

9

Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agents.

Yoshimoto Y, Augustine CK, Yoo JS, Zipfel PA, Selim MA, Pruitt SK, Friedman HS, Ali-Osman F, Tyler DS. Yoshimoto Y, et al. Among authors: tyler ds. Mol Cancer Ther. 2007 May;6(5):1492-500. doi: 10.1158/1535-7163.MCT-06-0718. Epub 2007 May 4. Mol Cancer Ther. 2007. PMID: 17483437

10

Future directions in regional treatment strategies for melanoma and sarcoma.

Beasley GM, Ross MI, Tyler DS. Beasley GM, et al. Among authors: tyler ds. Int J Hyperthermia. 2008 May;24(3):301-9. doi: 10.1080/02656730701827573. Int J Hyperthermia. 2008. PMID: 18393007 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

272 results

Search Page

Filters